Literature DB >> 25201221

Animal models of chronic obstructive pulmonary disease.

Sandra Pérez-Rial1, Álvaro Girón-Martínez1, Germán Peces-Barba2.   

Abstract

Animal models of disease have always been welcomed by the scientific community because they provide an approach to the investigation of certain aspects of the disease in question. Animal models of COPD cannot reproduce the heterogeneity of the disease and usually only manage to represent the disease in its milder stages. Moreover, airflow obstruction, the variable that determines patient diagnosis, not always taken into account in the models. For this reason, models have focused on the development of emphysema, easily detectable by lung morphometry, and have disregarded other components of the disease, such as airway injury or associated vascular changes. Continuous, long-term exposure to cigarette smoke is considered the main risk factor for this disease, justifying the fact that the cigarette smoke exposure model is the most widely used. Some variations on this basic model, related to exposure time, the association of other inducers or inhibitors, exacerbations or the use of transgenic animals to facilitate the identification of pathogenic pathways have been developed. Some variations or heterogeneity of this disease, then, can be reproduced and models can be designed for resolving researchers' questions on disease identification or treatment responses.
Copyright © 2014 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Animal model; Autoimmune; Autoinmune; Chronic obstructive pulmonary disease; Emphysema; Enfermedad pulmonar obstructiva crónica; Enfisema; Ensayos terapéuticos; Exacerbación; Exacerbation; Modelo animal; Smoking; Tabaco; Therapeutic assays; Transgenic animals; Transgénico

Mesh:

Substances:

Year:  2014        PMID: 25201221     DOI: 10.1016/j.arbres.2014.06.016

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  5 in total

1.  Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure.

Authors:  Zhongwei Sun; Feng Li; Xin Zhou; Wen Wang
Journal:  J Vis Exp       Date:  2017-08-25       Impact factor: 1.355

2.  Quercetin Improves Pulmonary Function and Prevents Emphysema Caused by Exposure to Cigarette Smoke in Male Mice.

Authors:  Natália Pereira da Silva Araújo; Natália Alves de Matos; Michel Oliveira; Ana Beatriz Farias de Souza; Thalles de Freitas Castro; Pedro Alves Machado-Júnior; Débora Maria Soares de Souza; André Talvani; Sílvia Dantas Cangussú; Rodrigo Cunha Alvim de Menezes; Frank Silva Bezerra
Journal:  Antioxidants (Basel)       Date:  2022-01-18

3.  Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats.

Authors:  Jian-Zhen Weng; Yan Wang; Tie-Ying Sun
Journal:  Chin Med J (Engl)       Date:  2019-03-05       Impact factor: 2.628

4.  Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease.

Authors:  Hyun-Taek Kim; Wenguang Yin; Young-June Jin; Paolo Panza; Felix Gunawan; Beate Grohmann; Carmen Buettner; Anna M Sokol; Jens Preussner; Stefan Guenther; Sawa Kostin; Clemens Ruppert; Aditya M Bhagwat; Xuefei Ma; Johannes Graumann; Mario Looso; Andreas Guenther; Robert S Adelstein; Stefan Offermanns; Didier Y R Stainier
Journal:  Nat Commun       Date:  2018-11-02       Impact factor: 14.919

5.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.